Recently, Chen Zhu, Vice chairman of the Standing Committee of the National People's Congress and Chairman of the Central Committee of the Peasants and Labor Party, and He Wei, Vice chairman of the National Committee of the Chinese People's Political Consultative Conference and executive vice chairman of the Central Committee of the Peasants and Labor Party, led the Central research group of the Peasants and Labor Party to Yangzijiang Pharmaceutical Group to carry out a special research on "Strengthening the national strategic science and technology strength of life and health". Yang Zhen, member of the Standing Committee of the National People's Congress and full-time Vice Chairman of the Central Committee of the Peasants and Labor Party, and Wang Xiang, deputy director of the Department of Innovation and High-tech Development of the National Development and Reform Commission, participated in the research. Zhou Jianmin, Vice Chairman of the CPPCC Provincial Committee and the chairman of the Rural Labor Party Provincial Committee, Xu Kaixin, Deputy minister of the United Front Work Department of the Provincial Party Committee, Shi Lijun, Secretary of the Taizhou Municipal Party Committee, Xu Jingren, chairman of Yangzijiang Pharmaceutical Group, accompanied the visit.

The research group inspected the TCM extraction production line of Jiangsu Longfengtang Chinese Medicine Co., LTD., understood the specific steps of automatic feeding, extraction, concentration and alcohol precipitation of Chinese medicinal materials in detail, carefully inquired about the production processes of single decoction and combined decoction of Chinese medicinal materials in the extraction stage, and adopted the whole process traceability system for Longfengtang to realize the source of Chinese medicinal materials can be checked, the quality can be controlled, and the direction can be traced. To ensure that the quality of the Chinese medicine products produced is reliable and fully affirmed.

Chairman Xu Jingren introduced the development of the company and the layout of new drug research and development to the research team. Yangzijiang Pharmaceutical takes the initiative to connect and serve the national innovation strategy, attaches great importance to research and development investment, continuously increases the development of innovative drugs, high-end generic drugs, exclusive Chinese medicine and other products, relying on high-level innovation research and development platforms such as the State Key Laboratory of New Pharmaceutical Technology and the National Engineering Research Center for Chinese Pharmaceutical Technology, and incubates a number of high-end pharmaceutical projects. Won three national Science and Technology progress awards.

Vice Chairman Chen Zhu praised the innovation achievements and development achievements of Yangzijiang Pharmaceutical, which adheres to the development of enterprises through science and technology, adheres to the inheritance of essence of traditional Chinese medicine, and adheres to the integrity and innovation. He carefully asked about the difficulties and problems that enterprises need to solve in drug research and development and process innovation, and said that the government and relevant parties will assist and guide enterprises to crack the "jam neck" technical problems, encourage enterprises to continue to play the main position and leading role in technological innovation during the "14th Five-Year Plan" period, strengthen basic research and original capabilities, and take the road of high-quality development. Contribute the wisdom and strength of the Yangtze River to building a healthy China.